GlobalDeal

Aravive, Inc.

Biotechnology · Houston, United States

aravive.com

About Aravive, Inc.

Aravive, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company is dedicated to advancing its proprietary platform that targets the GAS6-AXL signaling pathway, which plays a critical role in tumor growth and metastasis. Aravive's lead product candidate, AVB-500, is designed to inhibit this pathway and is currently being evaluated in clinical trials for various cancer indications. The company's mission is to improve patient outcomes through the development of novel therapeutics that address unmet medical needs in oncology.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Oncology, Clinical Trials, Drug Development, Biologics
Location
Houston, United States
Employees
11–50
Revenue (USD)
1–5M
Founded
2013

Products and services

Open Aravive, Inc. in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →